Skip to content
PLx Pharma Inc.
Board of Directors
Scientific Advisory Board
Products & Technology
PLxGuard Delivery System
Aspertec 325 mg
The PLxGuard Delivery System has the Potential to Improve Both New and Existing Drugs
Learn about the PLxGuard Delivery System
PLx Pharma Announces Publication of Positive Antiplatelet Data for Aspertec in Peer-Reviewed Medical Journal JACC
PLx Pharma and Dipexium Announce Merger Agreement
Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer
Unlocking Aspirin’s Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1
Mike Valentino Awarded CHPA’s Ivan D. Combe Lifetime Achievement Award
Low-Dose Aspirin-Induced Ulceration Is Attenuated by Aspirin-Phosphatidylcholine: A Randomized Clinical Trial.
Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients.